Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up

Forss, A; Clements, M; Myrelid, P; Strid, H; Soderman, C; Wagner, A; Andersson, D; Hjelm, F; Olen, O; Ludvigsson, JF; Halfvarson, J

Forss, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021; 56 (6): 680

Abstract

Background Prospectively and systematically collected real-world data on the effectiveness of ustekinumab (anti-interleukin-12/23) for treating Crohn'......

Full Text Link